{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:41:17Z","timestamp":1790779277498,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T00:00:00Z","timestamp":1390262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00774-013-0541-y","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T01:27:51Z","timestamp":1390181271000},"page":"636-644","source":"Crossref","is-referenced-by-count":6,"title":["Effects of pyrophosphate delivery in a peritoneal dialysis solution on bone tissue of apolipoprotein-E knockout mice with chronic kidney disease"],"prefix":"10.1007","volume":"32","author":[{"given":"Fellype C.","family":"Barreto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo B.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Benchitrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Rezg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Poirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Jorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman B.","family":"Dr\u00fceke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Riser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,21]]},"reference":[{"key":"541_CR1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1523-1755.2004.00894.x","volume":"66","author":"G Eknoyan","year":"2004","unstructured":"Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H (2004) The burden of kidney disease: improving global outcomes. Kidney Int 66:1310\u20131314","journal-title":"Kidney Int"},{"key":"541_CR2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2215\/CJN.04000609","volume":"1","author":"N Lameire","year":"2009","unstructured":"Lameire N, Van Biesen W, Vanholder R (2009) Did 20\u00a0years of technological innovations in hemodialysis contribute to better patient outcomes? Clin J Am Soc Nephrol 1:S30\u2013S40","journal-title":"Clin J Am Soc Nephrol"},{"key":"541_CR3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.12968\/hosp.2000.61.9.1419","volume":"61","author":"SK Burke","year":"2000","unstructured":"Burke SK (2000) Renagel: reducing serum phosphorus in haemodialysis patients. Hosp Med 61:622\u2013627","journal-title":"Hosp Med"},{"key":"541_CR4","first-page":"321","volume":"18","author":"MJ Holechek","year":"1991","unstructured":"Holechek MJ (1991) Medication review: an alternative phosphate binder\u2014calcium acetate. ANNA J 18:321\u2013322","journal-title":"ANNA J"},{"key":"541_CR5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/j.1875-9114.1990.tb02566.x","volume":"10","author":"J Egrie","year":"1990","unstructured":"Egrie J (1990) The cloning and production of recombinant human erythropoietin. Pharmacotherapy 10:S3\u2013S8","journal-title":"Pharmacotherapy"},{"key":"541_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0272-6386(99)70272-6","volume":"33","author":"T Depner","year":"1999","unstructured":"Depner T, Beck G, Daugirdas J, Kusek J, Eknoyan G (1999) Lessons from the hemodialysis (HEMO) study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis 33:142\u2013149","journal-title":"Am J Kidney Dis"},{"key":"541_CR7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Guerin AP, Marchais SJ, M\u00e9tivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731\u20131740","journal-title":"Nephrol Dial Transplant"},{"key":"541_CR8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ki.2010.70","volume":"77","author":"YW Chiu","year":"2010","unstructured":"Chiu YW, Adler SG, Budoff MJ, Takasu J, Ashai J, Mehrotra R (2010) Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int 77:1107\u20131114","journal-title":"Kidney Int"},{"key":"541_CR9","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/heartjnl-2011-301464","volume":"98","author":"F Bastos Gon\u00e7alves","year":"2012","unstructured":"Bastos Gon\u00e7alves F, Vo\u00fbte MT, Hoeks SE, Chonchol MB, Boersma EE, Stolker RJ, Verhagen HJ (2012) Calcification of the abdominal aorta as an independent predictor of cardiovascular events: a meta-analysis. Heart 98:988\u2013994","journal-title":"Heart"},{"key":"541_CR10","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","volume":"165","author":"MD Francis","year":"1969","unstructured":"Francis MD, Russell RGG, Fleisch H (1969) Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathologic calcification in vivo. Science 165:1264\u20131266","journal-title":"Science"},{"key":"541_CR11","first-page":"340","volume":"54","author":"H Fleisch","year":"1962","unstructured":"Fleisch H, Bisaz S (1962) The inhibitory role of pyrophosphate in calcification. J Physiol 54:340\u2013341","journal-title":"J Physiol"},{"key":"541_CR12","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","volume":"100","author":"CM Shanahan","year":"1999","unstructured":"Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME (1999) Medial localization of mineralization-regulating proteins in association with Monckeberg\u2019s sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168\u20132176","journal-title":"Circulation"},{"key":"541_CR13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/ajplegacy.1970.218.6.1757","volume":"218","author":"A Jung","year":"1970","unstructured":"Jung A, Russel RG, Bisaz S, Morgan DB, Fleisch H (1970) Fate of intravenously injected pyrophosphate-32p in dogs. Am J Physiol 218:1757\u20131764","journal-title":"Am J Physiol"},{"key":"541_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin JH (1996) Bisphosphonates: a review of their pharmacokinetic properties. Bone 18:75\u201385","journal-title":"Bone"},{"key":"541_CR15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0009-9236(95)90245-7","volume":"58","author":"BJ Gertz","year":"1995","unstructured":"Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG (1995) Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther 58:288\u2013298","journal-title":"Clin Pharmacol Ther"},{"key":"541_CR16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ki.2010.461","volume":"79","author":"WC O\u2019Neill","year":"2011","unstructured":"O\u2019Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL (2011) Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79:512\u2013517","journal-title":"Kidney Int"},{"key":"541_CR17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2008.26","volume":"73","author":"KA Lomashvili","year":"2008","unstructured":"Lomashvili KA, Garg P, Narisawa S, Millan JL, O\u2019Neill WC (2008) Up regulation of alkaline phosphatase and pyrophosphate hydrolysis; potential mechanism for uremic vascular calcification. Kidney Int 73:1024\u20131030","journal-title":"Kidney Int"},{"key":"541_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng1221","volume":"34","author":"F Rutsch","year":"2003","unstructured":"Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A et al (2003) Mutations in enpp1 are associated with \u2018idiopathic\u2019 infantile arterial calcification. Nat Genet 34:379\u20133781","journal-title":"Nat Genet"},{"key":"541_CR19","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.2004080694","volume":"16","author":"KA Lomashvili","year":"2005","unstructured":"Lomashvili KA, Khawandi W, O\u2019Neill WC (2005) Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16:2495\u20132500","journal-title":"J Am Soc Nephrol"},{"key":"541_CR20","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/ndt\/gfr039","volume":"26","author":"BL Riser","year":"2011","unstructured":"Riser BL, Barreto FC, Rezg R, Valaitis PW, Cook CS, White JA, Gass JH, Maizel J, Louvet L, Drueke TB, Holmes CJ, Massy ZA (2011) Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transplant 26:3349\u20133357","journal-title":"Nephrol Dial Transplant"},{"key":"541_CR21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000276666","volume":"29","author":"R Amerling","year":"2010","unstructured":"Amerling R, Harbord NB, Pullman J, Feinfeld DA (2010) Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series. Blood Purif 29:293\u2013299","journal-title":"Blood Purif"},{"key":"541_CR22","first-page":"S1","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) Kdigo clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 9:S1\u2013S130","journal-title":"Kidney Int"},{"key":"541_CR23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bone.2010.04.600","volume":"47","author":"IG Nikolov","year":"2010","unstructured":"Nikolov IG, Joki N, Nguyen-Khoa T, Ivanovski O, Phan O, Lacour B, Dr\u00fceke TB, Massy ZA, Dos Reis LM, Jorgetti V, Lafage-Proust MH (2010) Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure. Bone 47:156\u2013163","journal-title":"Bone"},{"key":"541_CR24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"541_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2008.10.043","volume":"205","author":"O Ivanovski","year":"2009","unstructured":"Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, Kamel S, Lacour B, Dr\u00fceke TB, Massy ZA (2009) The calcimimetic R-568 retards uremiaenhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE\u2212\/\u2212) mice. Atherosclerosis 205:55\u201362","journal-title":"Atherosclerosis"},{"key":"541_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.2004060495","volume":"16","author":"ZA Massy","year":"2005","unstructured":"Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Dr\u00fceke TB, Muntzel MS (2005) Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 16:109\u2013116","journal-title":"J Am Soc Nephrol"},{"key":"541_CR27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.7150\/ijbs.4538","volume":"8","author":"X Zhou","year":"2012","unstructured":"Zhou X, Cui Y, Zhou X, Han J (2012) Phosphate\/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models. Int J Biol Sci 8:778\u2013790","journal-title":"Int J Biol Sci"},{"key":"541_CR28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00228-012-1216-7","volume":"68","author":"N Maruotti","year":"2012","unstructured":"Maruotti N, Corrado A, Neve A, Cantatore FP (2012) Bisphosphonates: effects on osteoblast. Eur J Clin Pharmacol 68:1013\u20131018","journal-title":"Eur J Clin Pharmacol"},{"key":"541_CR29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","volume":"291","author":"V Viereck","year":"2002","unstructured":"Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Gr\u00fcndker C, Hofbauer LC (2002) Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 291:680\u2013686","journal-title":"Biochem Biophys Res Commun"},{"key":"541_CR30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1359\/jbmr.2004.19.1.147","volume":"19","author":"B Pan","year":"2004","unstructured":"Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, Zannettino AC (2004) The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res 19:147\u2013154","journal-title":"J Bone Miner Res"},{"key":"541_CR31","doi-asserted-by":"crossref","first-page":"15872","DOI":"10.1074\/jbc.M701116200","volume":"282","author":"WN Addison","year":"2007","unstructured":"Addison WN, Azari F, S\u00f8rensen ES, Kaartinen MT, McKee MD (2007) Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem 282:15872\u201315883","journal-title":"J Biol Chem"},{"key":"541_CR32","doi-asserted-by":"crossref","first-page":"e38393","DOI":"10.1371\/journal.pone.0038393","volume":"7","author":"BL Foster","year":"2012","unstructured":"Foster BL, Nagatomo KJ, Nociti FH Jr, Fong H, Dunn D, Tran AB, Wang W, Narisawa S, Mill\u00e1n JL, Somerman MJ (2012) Central role of pyrophosphate in acellular cementum formation. PLoS One 7:e38393","journal-title":"PLoS One"},{"key":"541_CR33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1101\/gad.1276205","volume":"19","author":"M Murshed","year":"2005","unstructured":"Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G (2005) Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19:1093\u20131104","journal-title":"Genes Dev"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-013-0541-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-013-0541-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-013-0541-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T10:29:42Z","timestamp":1716460182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-013-0541-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,21]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1007\/s00774-013-0541-y","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,21]]}}}